The lessen in paclitaxel CL noticed during the presence of zosuquidar brought about a rise in some time the plasma paclitaxel focus stays higher than 0.one mol L−one, which is known to get a marker of equally toxicity (neutropenia) and efficacy [1]. Although the outcome of zosuquidar over the toxicity https://salvadoru009itf2.bloguerosa.com/profile